Business Context and Reporting Period
This Form 8-K Current Report was filed by Envoy Medical, Inc. on June 19, 2025. The report discloses a corporate governance change involving the appointment of an Interim Chief Financial Officer effective June 23, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statement data.
Material Changes
The primary material change reported is the appointment of Robert Potashnick as Interim Chief Financial Officer. He will assume the duties of principal financial officer and principal accounting officer. The appointment is structured as a fractional consultant engagement through his entity, Oasis Business Consulting LLC.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It details Mr. Potashnick's professional background, including prior roles as CFO at Flutterbee Education Group and FOXO Technologies Inc., and experience at UnitedHealth Group and PricewaterhouseCoopers. The filing confirms no undisclosed arrangements or family relationships with board members.
Investor Verification Checklist
- Verify the terms of the Consulting Agreement (Exhibit 10.1) regarding compensation and duration.
- Confirm the effective start date of June 23, 2025, for the new Interim CFO.
- Review subsequent filings for the departure of the previous CFO, if applicable.
- Monitor the company's next periodic report (10-Q or 10-K) for updated financial metrics.